Rosaceiform eruption induced by cetuximab

European Journal of Dermatology

Volumn 20, Issue 3, 2010, Pages 392-393

  Fernández Torres, Rose ^a   Martínez Gomez, Walter ^a   Cuevas Santos, Jesús ^b   Paradela, Sabela ^a   Fonseca Capdevila, Eduardo ^a  

^a UNIVERSITY OF A CORUÑA   (Spain)

^b HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; CLINDAMYCIN; IRINOTECAN; METRONIDAZOLE; MINOCYCLINE; PREDNICARBATE;

ACNE; AGED; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; COLORECTAL CANCER; DRUG INDUCED DISEASE; ERYTHEMA; HISTOPATHOLOGY; HUMAN; LETTER; MALE; ROSACEA; SKIN BIOPSY;

ACNEIFORM ERUPTIONS; AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; BIOPSY; COLORECTAL NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; DRUG ERUPTIONS; HUMANS; MALE; RECEPTOR, EPIDERMAL GROWTH FACTOR; SKIN;

EID: 77952842796     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2010.0900     Document Type: Letter

References (6)

1. Hu JC, Sadeghi P, Pinter-Brown LC, Yashar S, Chiu MW. Cutaneous side effects of epidermal growth factor receptor inhibitors: Clinical presentation, pathogenesis, and management. J Am Acad Dermatol 2007; 56: 317-326 (Pubitemid 46091817)
2. Robert C, Soria JC, Spatz A, et al. Cutaneous side-effects of kinase inhibitors and blocking antibodies. Lancet Oncol 2005; 6: 491-500. (Pubitemid 40903630)
3. Katzer K, Tietze J, Klein E, Heinemann V, Ruzicka T, Wollenberg A. Topical therapy with nadifloxacin cream and prednicarbate cream improves acneiform eruptions caused by EGFR-inhibitor cetuximab-A report of 29 patients. Eur J Dermatol 2009; 20: 82-84
4. De Noronha E, Menezes NM, Lima R, et al. Description and management of cutaneous side effecrts during erlotinib and cetuximab treatment in lung and colorectal cancer patients: A prospective and descriptive study of 19 patients. Eur J Dermatol 2009; 19: 248-251
5. Patrizi A, Bianchi F, Neri I. Rosaceiform eruption induced by erlotinib. Dermatol Ther 2008; 21 (Suppl 2): S43-5.
6. Galimont-Collen AFS, Vos LE, Lavrijsen APM, Ouwerkerk J, Gelderblom H. Clasification and management of skin, hair, nail and mucosal side-effects of epidermal growth factor receptor (EGFR) inhibitors. Eur J Cancer 2007; 43: 845-851 (Pubitemid 46366684)